Global Active Pharmaceutical Ingredients (API) Market Insights, Forecast to 2025

Published: March 2019

No. of Pages: 140

Price:

Single User License: US $ 3900

Corporate User License: US $ 7800

Report Description
Table of Contents

The global Active Pharmaceutical Ingredients(API) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Active Pharmaceutical Ingredients(API) market based on company, product type, end user and key regions.

This report studies the global market size of Active Pharmaceutical Ingredients(API) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Active Pharmaceutical Ingredients(API) in these regions.
This research report categorizes the global Active Pharmaceutical Ingredients(API) market by top players/brands, region, type and end user. This report also studies the global Active Pharmaceutical Ingredients(API) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
- Pfizer
- Novartis International
- Sanofi
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Teva Pharmaceutical
- Eli Lilly and Company
- GlaxoSmithKline
- Merck & Co
- AbbVie
- Johnson & Johnson
- Bayer
- Sun Pharmaceutical Industries
- DSM
- Hisun Pharmacy
- Huahai Pharmaceutical
- North China Pharmaceutical Group
- Shandong Lukang Pharmaceutical
- Haerbin Pharmaceutical Group
- Shandong Xinhua Pharmaceutical
- Jiangsu Hengrui Medicine
- Lonza Group
- Aurobindo Pharma
- Lupin
- Biocon

Market size by Product
- Synthetic APIs
- Biotech APIs
Market size by End User
- Oncology
- Diabetes
- Cardiovascular Disease
- CNS and Neurological Disorders
- Endocrinology

Market size by Region
- North America
- - United States
- - Canada
- - Mexico
- Asia-Pacific
- - China
- - India
- - Japan
- - South Korea
- - Australia
- - Indonesia
- - Singapore
- - Malaysia
- - Philippines
- - Thailand
- - Vietnam
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Spain
- - Russia
- Central & South America
- - Brazil
- - Rest of Central & South America
- Middle East & Africa
- - GCC Countries
- - Turkey
- - Egypt
- - South Africa

The study objectives of this report are:
- To study and analyze the global Active Pharmaceutical Ingredients(API) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
- To understand the structure of Active Pharmaceutical Ingredients(API) market by identifying its various subsegments.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- Focuses on the key global Active Pharmaceutical Ingredients(API) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
- To project the value and sales volume of Active Pharmaceutical Ingredients(API) submarkets, with respect to key regions.
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredients(API) are as follows:
- History Year: 2014-2018
- Base Year: 2018
- Estimated Year: 2019
- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Active Pharmaceutical Ingredients(API) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Active Pharmaceutical Ingredients(API) Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Active Pharmaceutical Ingredients(API) Market Size Growth Rate by Product
1.4.2 Synthetic APIs
1.4.3 Biotech APIs
1.5 Market by End User
1.5.1 Global Active Pharmaceutical Ingredients(API) Market Size Growth Rate by End User
1.5.2 Oncology
1.5.3 Diabetes
1.5.4 Cardiovascular Disease
1.5.5 CNS and Neurological Disorders
1.5.6 Endocrinology
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Active Pharmaceutical Ingredients(API) Market Size
2.1.1 Global Active Pharmaceutical Ingredients(API) Revenue 2014-2025
2.1.2 Global Active Pharmaceutical Ingredients(API) Sales 2014-2025
2.2 Active Pharmaceutical Ingredients(API) Growth Rate by Regions
2.2.1 Global Active Pharmaceutical Ingredients(API) Sales by Regions
2.2.2 Global Active Pharmaceutical Ingredients(API) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Active Pharmaceutical Ingredients(API) Sales by Manufacturers
3.1.1 Active Pharmaceutical Ingredients(API) Sales by Manufacturers
3.1.2 Active Pharmaceutical Ingredients(API) Sales Market Share by Manufacturers
3.1.3 Global Active Pharmaceutical Ingredients(API) Market Concentration Ratio (CR5 and HHI)
3.2 Active Pharmaceutical Ingredients(API) Revenue by Manufacturers
3.2.1 Active Pharmaceutical Ingredients(API) Revenue by Manufacturers (2014-2019)
3.2.2 Active Pharmaceutical Ingredients(API) Revenue Share by Manufacturers (2014-2019)
3.3 Active Pharmaceutical Ingredients(API) Price by Manufacturers
3.4 Active Pharmaceutical Ingredients(API) Manufacturing Base Distribution, Product Types
3.4.1 Active Pharmaceutical Ingredients(API) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharmaceutical Ingredients(API) Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredients(API) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Active Pharmaceutical Ingredients(API) Sales by Product
4.2 Global Active Pharmaceutical Ingredients(API) Revenue by Product
4.3 Active Pharmaceutical Ingredients(API) Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Active Pharmaceutical Ingredients(API) Breakdown Data by End User

6 North America
6.1 North America Active Pharmaceutical Ingredients(API) by Countries
6.1.1 North America Active Pharmaceutical Ingredients(API) Sales by Countries
6.1.2 North America Active Pharmaceutical Ingredients(API) Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Active Pharmaceutical Ingredients(API) by Product
6.3 North America Active Pharmaceutical Ingredients(API) by End User

7 Europe
7.1 Europe Active Pharmaceutical Ingredients(API) by Countries
7.1.1 Europe Active Pharmaceutical Ingredients(API) Sales by Countries
7.1.2 Europe Active Pharmaceutical Ingredients(API) Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharmaceutical Ingredients(API) by Product
7.3 Europe Active Pharmaceutical Ingredients(API) by End User

8 Asia Pacific
8.1 Asia Pacific Active Pharmaceutical Ingredients(API) by Countries
8.1.1 Asia Pacific Active Pharmaceutical Ingredients(API) Sales by Countries
8.1.2 Asia Pacific Active Pharmaceutical Ingredients(API) Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Active Pharmaceutical Ingredients(API) by Product
8.3 Asia Pacific Active Pharmaceutical Ingredients(API) by End User

9 Central & South America
9.1 Central & South America Active Pharmaceutical Ingredients(API) by Countries
9.1.1 Central & South America Active Pharmaceutical Ingredients(API) Sales by Countries
9.1.2 Central & South America Active Pharmaceutical Ingredients(API) Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Active Pharmaceutical Ingredients(API) by Product
9.3 Central & South America Active Pharmaceutical Ingredients(API) by End User

10 Middle East and Africa
10.1 Middle East and Africa Active Pharmaceutical Ingredients(API) by Countries
10.1.1 Middle East and Africa Active Pharmaceutical Ingredients(API) Sales by Countries
10.1.2 Middle East and Africa Active Pharmaceutical Ingredients(API) Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Active Pharmaceutical Ingredients(API) by Product
10.3 Middle East and Africa Active Pharmaceutical Ingredients(API) by End User

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Business Overview
11.1.3 Pfizer Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Pfizer Active Pharmaceutical Ingredients(API) Products Offered
11.1.5 Pfizer Recent Development
11.2 Novartis International
11.2.1 Novartis International Company Details
11.2.2 Company Business Overview
11.2.3 Novartis International Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis International Active Pharmaceutical Ingredients(API) Products Offered
11.2.5 Novartis International Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sanofi Active Pharmaceutical Ingredients(API) Products Offered
11.3.5 Sanofi Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Company Business Overview
11.4.3 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Company Business Overview
11.5.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Products Offered
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Products Offered
11.6.5 Teva Pharmaceutical Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Company Business Overview
11.7.3 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Eli Lilly and Company Active Pharmaceutical Ingredients(API) Products Offered
11.7.5 Eli Lilly and Company Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 Company Business Overview
11.8.3 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.8.4 GlaxoSmithKline Active Pharmaceutical Ingredients(API) Products Offered
11.8.5 GlaxoSmithKline Recent Development
11.9 Merck & Co
11.9.1 Merck & Co Company Details
11.9.2 Company Business Overview
11.9.3 Merck & Co Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Merck & Co Active Pharmaceutical Ingredients(API) Products Offered
11.9.5 Merck & Co Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Details
11.10.2 Company Business Overview
11.10.3 AbbVie Active Pharmaceutical Ingredients(API) Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AbbVie Active Pharmaceutical Ingredients(API) Products Offered
11.10.5 AbbVie Recent Development
11.11 Johnson & Johnson
11.12 Bayer
11.13 Sun Pharmaceutical Industries
11.14 DSM
11.15 Hisun Pharmacy
11.16 Huahai Pharmaceutical
11.17 North China Pharmaceutical Group
11.18 Shandong Lukang Pharmaceutical
11.19 Haerbin Pharmaceutical Group
11.20 Shandong Xinhua Pharmaceutical
11.21 Jiangsu Hengrui Medicine
11.22 Lonza Group
11.23 Aurobindo Pharma
11.24 Lupin
11.25 Biocon

12 Future Forecast
12.1 Active Pharmaceutical Ingredients(API) Market Forecast by Regions
12.1.1 Global Active Pharmaceutical Ingredients(API) Sales Forecast by Regions 2019-2025
12.1.2 Global Active Pharmaceutical Ingredients(API) Revenue Forecast by Regions 2019-2025
12.2 Active Pharmaceutical Ingredients(API) Market Forecast by Product
12.2.1 Global Active Pharmaceutical Ingredients(API) Sales Forecast by Product 2019-2025
12.2.2 Global Active Pharmaceutical Ingredients(API) Revenue Forecast by Product 2019-2025
12.3 Active Pharmaceutical Ingredients(API) Market Forecast by End User
12.4 North America Active Pharmaceutical Ingredients(API) Forecast
12.5 Europe Active Pharmaceutical Ingredients(API) Forecast
12.6 Asia Pacific Active Pharmaceutical Ingredients(API) Forecast
12.7 Central & South America Active Pharmaceutical Ingredients(API) Forecast
12.8 Middle East and Africa Active Pharmaceutical Ingredients(API) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Active Pharmaceutical Ingredients(API) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Active Pharmaceutical Ingredients(API) Product Picture
Table Active Pharmaceutical Ingredients(API) Market Segments
Table Key Manufacturers Active Pharmaceutical Ingredients(API) Covered
Table Global Active Pharmaceutical Ingredients(API) Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Active Pharmaceutical Ingredients(API) Sales Market Share by Product 2014-2025
Figure Synthetic APIs Product Picture
Table Major Manufacturers of Synthetic APIs
Figure Biotech APIs Product Picture
Table Major Manufacturers of Biotech APIs
Table Global Active Pharmaceutical Ingredients(API) Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Oncology
Figure Diabetes
Figure Cardiovascular Disease
Figure CNS and Neurological Disorders
Figure Endocrinology
Figure Active Pharmaceutical Ingredients(API) Report Years Considered
Figure Global Active Pharmaceutical Ingredients(API) Market Size 2014-2025 (Million US$)
Figure Global Active Pharmaceutical Ingredients(API) Sales 2014-2025 (K Units)
Table Global Active Pharmaceutical Ingredients(API) Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Active Pharmaceutical Ingredients(API) Sales by Regions 2014-2019 (K Units)
Table Global Active Pharmaceutical Ingredients(API) Sales Market Share by Regions 2014-2019
Figure Global Active Pharmaceutical Ingredients(API) Sales Market Share by Regions 2014-2019
Figure 2018 Global Active Pharmaceutical Ingredients(API) Sales Market Share by Regions
Table Global Active Pharmaceutical Ingredients(API) Revenue by Regions 2014-2019 (Million US$)
Table Global Active Pharmaceutical Ingredients(API) Revenue Market Share by Regions 2014-2019
Figure Global Active Pharmaceutical Ingredients(API) Revenue Market Share by Regions 2014-2019
Figure 2018 Global Active Pharmaceutical Ingredients(API) Revenue Market Share by Regions
Table Global Active Pharmaceutical Ingredients(API) Sales by Manufacturers (2014-2019) (K Units)
Table Global Active Pharmaceutical Ingredients(API) Sales Share by Manufacturers (2014-2019)
Figure Global Active Pharmaceutical Ingredients(API) Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Active Pharmaceutical Ingredients(API) Revenue by Manufacturers (2014-2019) (Million USD)
Table Active Pharmaceutical Ingredients(API) Revenue Share by Manufacturers (2014-2019)
Figure Active Pharmaceutical Ingredients(API) Value Share by Manufacturers in 2018
Table Key Manufacturers Active Pharmaceutical Ingredients(API) Price (2014-2019) (USD/Unit)
Table Active Pharmaceutical Ingredients(API) Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Active Pharmaceutical Ingredients(API) Product Type
Table Date of International Manufacturers Enter into Active Pharmaceutical Ingredients(API) Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Active Pharmaceutical Ingredients(API) Sales by Product (2014-2019) (K Units)
Table Global Active Pharmaceutical Ingredients(API) Sales Share by Product (2014-2019)
Figure Global Active Pharmaceutical Ingredients(API) Sales Market Share by Product (2014-2019)
Figure Global Active Pharmaceutical Ingredients(API) Sales Market Share by Product in 2018
Table Global Active Pharmaceutical Ingredients(API) Revenue by Product (2014-2019) (Million US$)
Table Global Active Pharmaceutical Ingredients(API) Revenue Share by Product (2014-2019)
Figure Global Active Pharmaceutical Ingredients(API) Revenue Market Share by Product (2014-2019)
Figure Global Active Pharmaceutical Ingredients(API) Revenue Market Share by Product in 2018
Table Active Pharmaceutical Ingredients(API) Price by Product 2014-2019 (USD/Unit)
Table Global Active Pharmaceutical Ingredients(API) Sales by End User (2014-2019) (K Units)
Table Global Active Pharmaceutical Ingredients(API) Sales Share by End User (2014-2019)
Figure Global Sales Active Pharmaceutical Ingredients(API) Market Share by End User (2014-2019)
Figure Global Sales Active Pharmaceutical Ingredients(API) Market Share by End User in 2018
Figure North America Active Pharmaceutical Ingredients(API) Sales Growth Rate 2014-2019 (K Units)
Figure North America Active Pharmaceutical Ingredients(API) Revenue Growth Rate 2014-2019 (Million US$)
Table North America Active Pharmaceutical Ingredients(API) Sales by Countries (2014-2019) (K Units)
Table North America Active Pharmaceutical Ingredients(API) Sales Market Share by Countries (2014-2019)
Figure 2018 North America Active Pharmaceutical Ingredients(API) Sales Market Share by Countries
Table North America Active Pharmaceutical Ingredients(API) Revenue by Countries (2014-2019) (Million US$)
Table North America Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries
Figure United States Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure United States Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Canada Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Table North America Active Pharmaceutical Ingredients(API) Sales by Product (2014-2019) (K Units)
Table North America Active Pharmaceutical Ingredients(API) Sales Market Share by Product (2014-2019)
Figure 2018 North America Active Pharmaceutical Ingredients(API) Market Share by Product
Table North America Active Pharmaceutical Ingredients(API) Sales by End User (2014-2019) (K Units)
Table North America Active Pharmaceutical Ingredients(API) Sales Market Share by End User (2014-2019)
Figure 2018 North America Active Pharmaceutical Ingredients(API) Market Share by End User
Figure Europe Active Pharmaceutical Ingredients(API) Sales Growth Rate 2014-2019 (K Units)
Figure Europe Active Pharmaceutical Ingredients(API) Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Active Pharmaceutical Ingredients(API) Sales by Countries (2014-2019) (K Units)
Table Europe Active Pharmaceutical Ingredients(API) Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Active Pharmaceutical Ingredients(API) Sales Market Share by Countries
Table Europe Active Pharmaceutical Ingredients(API) Revenue by Countries (2014-2019) (Million US$)
Table Europe Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries
Figure Germany Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Germany Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure France Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure France Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure UK Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Italy Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Russia Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Active Pharmaceutical Ingredients(API) Sales by Product (2014-2019) (K Units)
Table Europe Active Pharmaceutical Ingredients(API) Sales Market Share by Product (2014-2019)
Figure 2018 Europe Active Pharmaceutical Ingredients(API) Market Share by Product
Table Europe Active Pharmaceutical Ingredients(API) Sales by End User (2014-2019) (K Units)
Table Europe Active Pharmaceutical Ingredients(API) Sales Market Share by End User (2014-2019)
Figure 2018 Europe Active Pharmaceutical Ingredients(API) Market Share by End User
Figure Asia Pacific Active Pharmaceutical Ingredients(API) Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Active Pharmaceutical Ingredients(API) Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredients(API) Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Active Pharmaceutical Ingredients(API) Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Active Pharmaceutical Ingredients(API) Sales Market Share by Countries
Table Asia Pacific Active Pharmaceutical Ingredients(API) Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries
Figure China Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure China Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Japan Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Korea Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure India Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure India Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Australia Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Active Pharmaceutical Ingredients(API) Sales by Product (2014-2019) (K Units)
Table Asia Pacific Active Pharmaceutical Ingredients(API) Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Active Pharmaceutical Ingredients(API) Market Share by Product
Table Asia Pacific Active Pharmaceutical Ingredients(API) Sales by End User (2014-2019) (K Units)
Table Asia Pacific Active Pharmaceutical Ingredients(API) Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Active Pharmaceutical Ingredients(API) Market Share by End User
Figure Central & South America Active Pharmaceutical Ingredients(API) Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Active Pharmaceutical Ingredients(API) Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Active Pharmaceutical Ingredients(API) Sales by Countries (2014-2019) (K Units)
Table Central & South America Active Pharmaceutical Ingredients(API) Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Active Pharmaceutical Ingredients(API) Sales Market Share by Countries
Table Central & South America Active Pharmaceutical Ingredients(API) Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries
Figure Brazil Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Active Pharmaceutical Ingredients(API) Sales by Product (2014-2019) (K Units)
Table Central & South America Active Pharmaceutical Ingredients(API) Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Active Pharmaceutical Ingredients(API) Market Share by Product
Table Central & South America Active Pharmaceutical Ingredients(API) Sales by End User (2014-2019) (K Units)
Table Central & South America Active Pharmaceutical Ingredients(API) Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Active Pharmaceutical Ingredients(API) Market Share by End User
Figure Middle East and Africa Active Pharmaceutical Ingredients(API) Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Active Pharmaceutical Ingredients(API) Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredients(API) Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Active Pharmaceutical Ingredients(API) Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients(API) Sales Market Share by Countries
Table Middle East and Africa Active Pharmaceutical Ingredients(API) Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients(API) Revenue Market Share by Countries
Figure GCC Countries Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Active Pharmaceutical Ingredients(API) Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Active Pharmaceutical Ingredients(API) Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Active Pharmaceutical Ingredients(API) Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Active Pharmaceutical Ingredients(API) Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients(API) Market Share by Product
Table Middle East and Africa Active Pharmaceutical Ingredients(API) Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Active Pharmaceutical Ingredients(API) Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients(API) Market Share by End User
Table Pfizer Company Details
Table Pfizer Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development

Table Novartis International Company Details
Table Novartis International Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis International Recent Development

Table Sanofi Company Details
Table Sanofi Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development

Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development

Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development

Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Recent Development

Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly and Company Recent Development

Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development

Table Merck & Co Company Details
Table Merck & Co Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck & Co Recent Development

Table AbbVie Company Details
Table AbbVie Active Pharmaceutical Ingredients(API) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development

Table Johnson & Johnson Company Details
Table Bayer Company Details
Table Sun Pharmaceutical Industries Company Details
Table DSM Company Details
Table Hisun Pharmacy Company Details
Table Huahai Pharmaceutical Company Details
Table North China Pharmaceutical Group Company Details
Table Shandong Lukang Pharmaceutical Company Details
Table Haerbin Pharmaceutical Group Company Details
Table Shandong Xinhua Pharmaceutical Company Details
Table Jiangsu Hengrui Medicine Company Details
Table Lonza Group Company Details
Table Aurobindo Pharma Company Details
Table Lupin Company Details
Table Biocon Company Details
Table Global Active Pharmaceutical Ingredients(API) Sales Forecast by Regions 2019-2025 (K Units)
Table Global Active Pharmaceutical Ingredients(API) Sales Market Share Forecast by Regions 2019-2025
Table Global Active Pharmaceutical Ingredients(API) Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Active Pharmaceutical Ingredients(API) Revenue Market Share Forecast by Regions 2019-2025
Table Global Active Pharmaceutical Ingredients(API) Sales Forecast by Product 2019-2025 (K Units)
Table Global Active Pharmaceutical Ingredients(API) Sales Market Share Forecast by Product 2019-2025
Table Global Active Pharmaceutical Ingredients(API) Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Active Pharmaceutical Ingredients(API) Revenue Market Share Forecast by Product 2019-2025
Table Global Active Pharmaceutical Ingredients(API) Sales Forecast by End User 2019-2025 (K Units)
Table Global Active Pharmaceutical Ingredients(API) Sales Market Share Forecast by End User 2019-2025
Figure North America Active Pharmaceutical Ingredients(API) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Active Pharmaceutical Ingredients(API) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Active Pharmaceutical Ingredients(API) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Active Pharmaceutical Ingredients(API) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Active Pharmaceutical Ingredients(API) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Active Pharmaceutical Ingredients(API) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Active Pharmaceutical Ingredients(API) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Active Pharmaceutical Ingredients(API) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Active Pharmaceutical Ingredients(API) Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Active Pharmaceutical Ingredients(API) Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Active Pharmaceutical Ingredients(API) Value Chain
Table Active Pharmaceutical Ingredients(API) Customers List
Table Active Pharmaceutical Ingredients(API) Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group354686

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Active Pharmaceutical Ingredients (API) Sales Market Report 2023 The global Active Pharmaceutical Ingredients (API) market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Active Pharmaceutical Ingredients (API) market will be able to gain...
Global Active Pharmaceutical Ingredients (API) Market Research Report 2023 This report aims to provide a comprehensive presentation of the global market for Active Pharmaceutical Ingredients (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competit...
Global Active Pharmaceutical Ingredients (API) CDMO Market Research Report 2023 This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Active Pharmaceutical Ingredients (API) CDMO market with multiple angles, which provides s...
Global Duloxetine Active Pharmaceutical Ingredients (API) Market Research Report 2023 Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical formulations. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Moreover, it is used to help relieve n...
Global Active Pharmaceutical Ingredients (API) Market Insights: Impact of COVID-19 and Future Expectations to 2028 The Active Pharmaceutical Ingredients (API) market revenue was 222.27 Million USD in 2022, and will reach 326.32 Million USD in 2028, with a CAGR of 6.61% during 2022-2028. This report elaborates the market size, market characteristics...
Global Veterinary Active Pharmaceutical Ingredients (API) Market Research Report 2023 Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxi...
Global Active Pharmaceutical Ingredients (API) Market Growth 2023-2029 An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natura...
Active Pharmaceutical Ingredients (API) Market, Global Outlook and Forecast 2023-2029 An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natura...
Global Active Pharmaceutical Ingredients (API) CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029 According to our (Global Info Research) latest study, the global Active Pharmaceutical Ingredients (API) CDMO market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review per...
Global Active Pharmaceutical Ingredients (API) CDMO Supply, Demand and Key Producers, 2023-2029 The global Active Pharmaceutical Ingredients (API) CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029). This report studies the global Active Pharmaceutical Ingred...
Global Active Pharmaceutical Ingredients (API) Professional Survey Report 2023, Forecast to 2028 API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. For example, an active ingredient to relieve pain is included in a painkiller. This is called API. Our market research experts provide qualitati...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *

We're Here To Help You

Request for Sample of this report